NCT04219254 2026-02-25A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid TumorsBioInvent International ABPhase 1/2 Recruiting197 enrolled
NCT06462794 2024-09-19First In Human Study of CX-801 in Advanced Solid TumorsCytomX TherapeuticsPhase 1 Recruiting121 enrolled